Recombinant human interferon α2b for injection

This product is produced by recombinant E. coli carrying the human leukocyte interferon α2b gene plasmid. It has broad-spectrum antiviral, inhibits cell proliferation and improves immune function. Improving immune function includes enhancing the phagocytic effect of macrophages, enhancing the cytotoxicity of lymphocytes to target cells and the function of natural killer cells.

Recombinant human interferon α2b, human albumin, sodium chloride

Colorless, transparent, clear liquid with no insoluble matter visible to the naked eye.

It can be used to treat acute and chronic viral hepatitis (type B and type C), genital warts, hairy cell leukemia, chronic myeloid leukemia, lymphoma, AIDS-related Kaposi's sarcoma, malignant melanoma and other diseases.

This product can be injected intramuscularly, subcutaneously, and intralesionally. 1. Chronic hepatitis B: The recommended dose is 3 to 5 million international units (IU) each time, injected once a day or every other day. A course of treatment is 3 to 6 months. The doctor can adjust the dose according to the patient's specific situation. 2. Chronic hepatitis C: The recommended dose is 3 to 5 million international units (IU) each time, injected once a day or every other day, and a course of treatment is 3 to 6 months. The doctor can adjust the dose according to the patient's specific situation. 3. Genital warts: The recommended dose is 1 to 3 million international units (IU) each time, injected three times a week every other day. A course of treatment is 1 to 2 months. 4.

The most common adverse reactions to this product include fever, chills, fatigue, headache, muscle aches, anorexia and other flu-like symptoms. Adding antipyretic analgesics (paracetamol, etc.) can alleviate or eliminate these symptoms, and these symptoms can also be alleviated with continued medication or dosage adjustment. Common abnormalities in hematological indicators include leukopenia, thrombocytopenia and increased transaminase. References: Other adverse reactions of alpha interferon reported in the literature include: diarrhea, nausea, hypertension, hypotension, vomiting, joint pain, impaired perception, mental confusion, dizziness, movement disorders, paresthesia, anxiety, depression, tension, drowsiness, hair loss, transient rash, itching; and rare thigh cramps, constipation, insomnia, herpes eruption, herpes labialis (non-herpetic), rash, urticaria, hot flashes

Patients with a history of allergy to interferon α2b or other ingredients of this preparation, as well as patients with severe liver, kidney and bone marrow dysfunction should not use this product.

Store at 2-8℃. Valid for two years.

5 million IU/vial

Beijing Yuance Pharmaceutical Co., Ltd.

• Founded in:

  1997-02-03

• Address:

  Factory Building No. 9, Longsheng Industrial Park, No. 7 Rongchang East Street, Beijing Economic and Technological Development Zone, Beijing

• Tax NO.:

  9111030263378882XT

• Registered Funds:

  10.246 million yuan

• Website:

  Log in to view

• Email:

  Log in to view